These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26646427)

  • 21. NEL-Like Molecule-1 (Nell1) Is Regulated by Bone Morphogenetic Protein 9 (BMP9) and Potentiates BMP9-Induced Osteogenic Differentiation at the Expense of Adipogenesis in Mesenchymal Stem Cells.
    Wang J; Liao J; Zhang F; Song D; Lu M; Liu J; Wei Q; Tang S; Liu H; Fan J; Zou Y; Guo D; Huang J; Liu F; Ma C; Hu X; Li L; Qu X; Chen L; Weng Y; Lee MJ; He TC; Reid RR; Zhang J
    Cell Physiol Biochem; 2017; 41(2):484-500. PubMed ID: 28214873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
    Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
    Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
    Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
    Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
    J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells.
    Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J
    Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway.
    Chen B; Zheng D; Liu C; Bhandari A; Hirachan S; Shen C; Mainali S; Li H; Jiang W; Xu J; Zhang X; Tang K; Zhang W
    Pathol Res Pract; 2023 Feb; 242():154325. PubMed ID: 36680929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
    Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
    PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
    Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
    Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma.
    Fujiwara M; Kashima TG; Kunita A; Kii I; Komura D; Grigoriadis AE; Kudo A; Aburatani H; Fukayama M
    Tumour Biol; 2011 Jun; 32(3):611-22. PubMed ID: 21360024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
    Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
    World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.
    Zhang J; Liang JH; Huang JG
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis.
    Ning X; Sun S; Zhang K; Liang J; Chuai Y; Li Y; Wang X
    PLoS One; 2012; 7(1):e30185. PubMed ID: 22295074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
    Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
    PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins.
    Nowotny M; Spiechowicz M; Jastrzebska B; Filipek A; Kitagawa K; Kuznicki J
    J Biol Chem; 2003 Jul; 278(29):26923-8. PubMed ID: 12746458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway.
    Tu B; Peng ZX; Fan QM; Du L; Yan W; Tang TT
    Exp Cell Res; 2014 Jan; 320(1):164-73. PubMed ID: 24183998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
    Liu X; Geng Z; Ding X; Lou Y; Zhang X
    Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
    Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
    Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.